drugset / Trial / NCT02184455
Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
Phase 1
Completed
11 enrolled
Dr. Paul F. Gratzer
Canadian Institutes of Health Research (CIHR) · collabNova Scotia Health Authority · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical trial is to perform a limited pilot study to determine the safety and feasibility of DermGEN in the treatment of non-healing diabetic foot ulcers (DFU). This will be a one-arm prospective study. It is hypothesized that DermGEN treatment will result in positive healing outcomes with no significant adverse effects.
Timeline
- Start
- 2016-07-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DermGEN | Unknown | — | — |